Search - tctmd.com

Displaying 161 - 180 of 1661

Sort: Relevancy | Date

News Industry News

Concept Medical receives US FDA approval for MagicTouch AVF indication, their fifth US clinical study approval for the MagicTouch portfolio

April 03, 2024

News Daily News

FDA Approves TriClip TEER Device for Tricuspid Repair

L.A. McKeown

April 02, 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

News Daily News

DCB in STEMI Match DES Through 5 Years: REVELATION

Caitlin E. Cox

March 27, 2024

News Daily News

Abiomed Recalls Labeling for Left-Sided Impella Pumps: FDA

Caitlin E. Cox

March 21, 2024

News Conference News CRT 2024

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

L.A. McKeown

March 15, 2024

News Daily News

Occupational Hazard? CTO Cases Drive Up Operators’ BP, Heart Rates

Yael L. Maxwell

March 11, 2024

Presentation THT 2024

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

Presenter: James W. Schurr

March 06, 2024

Presentation THT Abstracts 2024

Clinical Outcomes and the Impact of SCAI Stage among ProtekDuo Right Ventricular Assist Device Recipients with Cardiogenic Shock: A Report from the Cardiogenic Shock Working Group

Presenter: Kevin John

March 05, 2024

Presentation THT 2024

PVC-Induced Cardiomyopathy: Ablation Is the Treatment of Choice

Presenter: William Hucker

March 05, 2024

Presentation THT 2024

The Impella Portfolio of Devices for Cardiogenic Shock (Left-Sided Support)

Presenter: Justin Fried

March 05, 2024

Presentation THT 2024

Cardiogenic Shock: The Urgent Need for Innovation in Devices and Technologies for Shock

Presenter: Navin K. Kapur

March 05, 2024

Presentation THT 2024

Early Experience With Devices That Reduce Kidney Vascular Afterload From the Veins

Presenter: Ulrich P. Jorde

March 04, 2024

Presentation THT 2024

Early Experience With Devices That Increase Kidney Perfusion From the Aorta

Presenter: Jennifer A. Cowger

March 04, 2024

Presentation THT 2024

Mechanisms of Diuretic Resistance

Presenter: Jeffrey Testani

March 04, 2024

Presentation THT 2024

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

News Daily News

Real-life Patients Do Well With Intravascular Lithotripsy: Spanish Registry

Caitlin E. Cox

March 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2024

Shelley Wood

March 01, 2024

News Daily News

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

L.A. McKeown

March 01, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

Advertisement

Concept Medical receives US FDA approval for MagicTouch AVF indication, their fifth US clinical study approval for the MagicTouch portfolio

FDA Approves TriClip TEER Device for Tricuspid Repair

What’s Going to Be Hot at ACC 2024

DCB in STEMI Match DES Through 5 Years: REVELATION

Abiomed Recalls Labeling for Left-Sided Impella Pumps: FDA

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

Occupational Hazard? CTO Cases Drive Up Operators’ BP, Heart Rates

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

Clinical Outcomes and the Impact of SCAI Stage among ProtekDuo Right Ventricular Assist Device Recipients with Cardiogenic Shock: A Report from the Cardiogenic Shock Working Group

PVC-Induced Cardiomyopathy: Ablation Is the Treatment of Choice

The Impella Portfolio of Devices for Cardiogenic Shock (Left-Sided Support)

Cardiogenic Shock: The Urgent Need for Innovation in Devices and Technologies for Shock

Early Experience With Devices That Reduce Kidney Vascular Afterload From the Veins

Early Experience With Devices That Increase Kidney Perfusion From the Aorta

Mechanisms of Diuretic Resistance

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Real-life Patients Do Well With Intravascular Lithotripsy: Spanish Registry

TCTMD’s Top 10 Most Popular Stories for February 2024

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content